Objective-The leukocyte heme-enzyme MPO (myeloperoxidase) exerts proinflammatory effects on the vascular system primarily linked to its catalytic properties. Recent studies have shown that MPO, depending on its cationic charge, mediates neutrophil recruitment and activation. Here, we further investigated MPO's extracatalytic properties and its effect on endothelial glycocalyx (EG) integrity. Approach and Results-In vivo staining of murine cremaster muscle vessels with Alcian Blue 8GX provided evidence of an MPO-dependent decrease in anionic charge of the EG. MPO binding to the glycocalyx was further characterized using Chinese hamster ovary cells and its glycosaminoglycan mutants-pgsA-745 (mutant Chinese hamster ovary cells lacking heparan sulfate and chondroitin sulfate glycosaminoglycan) and pgsD-677 (mutant Chinese hamster ovary cells lacking heparan sulfate glycosaminoglycan), which revealed heparan sulfate as the main mediator of MPO binding. Further, EG integrity was assessed in terms of thickness using intravital microscopy of murine cremaster muscle. A significant reduction in EG thickness was observed on infusion of catalytically active MPO, as well as mutant inactive MPO and cationic polymer polylysine. Similar effects were also observed in wild-type mice after a local inflammatory stimulus but not in MPO-knockout mice. The reduction in EG thickness was reversed after removal of vessel-bound MPO, suggesting a possible physical collapse of the EG. Last, experiments with in vivo neutrophil depletion revealed that MPO also induced neutrophil-mediated shedding of the EG core protein, Sdc1 (syndecan-1). via association with CD11b/CD18 integrins. 16 In our previous study, we found that MPO acts as mediator of neutrophil recruitment dependent on its cationic surface charge. 17 However, the precise mechanism of MPO's charge-mediated neutrophil recruitment and its functional consequences on the glycocalyx layer still remain unclear.
I
t was in the 1960s that the endothelial glycocalyx (EG) was first visualized and studied. 1 Subsequently, the EG's crucial role in maintaining vessel homeostasis was established. Being at the border between the endothelial cell and blood/ plasma, the EG acts as a vascular barrier, but also as a hub for major plasma proteins to dock to its sugar-protein moieties. Basic and acidic proteins such as albumin or orosomucoid modulate the charge and permeability of the EG layer. 2, 3 It is now evident that the EG has a key function in vascular physiology, whether in maintaining vessel permeability 4, 5 or in mechanotransduction. 6, 7 Because of its highly anionic nature, mesh-like structure and role as a haven for adhesion molecules, it is a major mediator of blood cell and vessel wall interactions. [8] [9] [10] See accompanying editorial on page 1676
The heme-containing peroxidase, MPO (myeloperoxidase) is classically known for its bactericidal function and its contribution toward inflammatory processes, which are dependent on its enzymatic activity. It is the most abundant protein found in neutrophil granules and in a healthy state can reach plasma concentrations up to 40 ng/mL. 11 On intraluminal release from neutrophils, MPO binds to the vessel wall, accumulates along the endothelium and is transcytosed to the subendothelial space, where it oxidatively targets extracellular matrix proteins 12 and reduces nitric oxide bioavailability. 13, 14 A unique feature of MPO is its basic nature, with an isoelectric point of >10. This is because of the presence of a large number of arginine and lysine residues, rendering it a high cationic charge at physiological pH. 15 This feature enables MPO to exhibit proinflammatory properties independent of its catalytic function. It is known that MPO activates neutrophils
However, the precise mechanism of MPO's charge-mediated neutrophil recruitment and its functional consequences on the glycocalyx layer still remain unclear.
The EG layer is highly vulnerable to charge modification, which is exploited for staining purposes using cationic molecules for electron microscopy. There is evidence that modification of the EG charge leads to structural changes, influencing EG barrier properties. 18 Therefore, this study was established to investigate the modulation of the EG by MPO. Here, we demonstrate that MPO leads to a collapse of the EG via physical interaction with heparan sulfate glycosaminoglycans (GAG), causing Sdc1 (syndecan-1) shedding in a neutrophil-dependent manner. Such examples of MPO's extracatalytic functions provide unique insights into the enzyme's alternative role in mediating vascular inflammation.
Materials and Methods
The authors declare that all supporting data are available within the article and in the online-only Data Supplement.
MPO Binding Studies

Cell Culture
Wild-type (WT) Chinese hamster ovary cells (CHO, ATCC CCL-61) and its mutant cell lines pgsA-745 (mutant CHO cell lacking heparan sulfate and chondroitin sulfate GAG; ATCC CRL-2242) and pgsD-677 (mutant CHO cell lacking heparan sulfate GAG; ATCC CRL-2244) were cultured in Kaighn's modified Ham's F-12 medium (ATCC). Human umbilical vein endothelial cells (Lonza) were cultured in EBM-2 medium with supplements (Lonza; Major Resources Table in the online-only Data Supplement). Cells were treated with purified isolated human MPO (13 nmol/L, Planta Natural Products number 700-03-001) in Hanks' balanced salt solution (HBSS with calcium and magnesium, Invitrogen) with 0.5% bovine serum albumin for 2 hours. Cells were then washed with HBSS and further used for MPO binding studies. Cells were lysed in a buffer containing 0.15 mol/L Trizma hydrochloride (Sigma), 2.5 mol/L Sucrose (Merck), 0.03 mol/L ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA, Sigma), ethylenediaminetetraacetic acid (EDTA, AppliChem), 0.5 mmol/L phenylmethylsulfonyl fluoride (PMSF, Sigma), 0.5% Triton X-100 (Sigma), cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail (Roche, 1 tablet/10 mL), and PhosSTOP (Roche, 1 tablet/10 mL).
MPO Activity Assay
MPO activity in cell lysates was determined by adding an aliquot of cell lysate to 43 mmol/L NaH 2 PO 4 (pH 5.4, Carl Roth), 1.2 mmol/L tetramethylbenzidine (Sigma) dissolved in dimethylformamide (Sigma) and 100 µmol/L H 2 O 2 . Absorbance kinetics was measured spectrophotometrically at 655 nm. MPO activity was adjusted for cell number as determined by cell counts from cells grown under the same conditions.
Western Blotting
For quantification of cell-bound MPO, proteins from cell lysates were separated using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted on a nitrocellulose membrane (Bio-Rad). The blots were blocked with 5% milk powder (Carl Roth) and incubated overnight at 4°C with primary antibody against MPO (0.25 µg/mL, Rabbit polyclonal IgG, Calbiochem number 475915). Horseradish peroxidase conjugated goat anti-rabbit IgG (0.1 µg/mL, Vector number PI1000) was used as a secondary antibody followed by chemiluminescence detection (Major Resources  Table in the online-only Data Supplement).
Immunohistochemistry
Cell monolayers were fixed with 4% paraformaldehyde (PFA, VWR) followed by permeabilization using 0.1% Triton X-100 in phosphate buffered saline (PBS, Sigma) and blocking for 2 hours in 10% goat serum in PBS. Cells were stained overnight at 4°C with rabbit anti-MPO IgG (3.3 µg/mL, Calbiochem number 475915), mouse antiheparan sulfate IgG (5 µg/mL, USBio, number H1890) and mouse monoclonal anti-tubulin IgG (10 µg/mL, Sigma number T9026). Alexa 488 conjugated goat anti-rabbit IgG and Alexa 594 conjugated goat anti-mouse IgG (both 1 µg/mL, Thermo Fisher number a11034 and number a21042, respectively) were used as secondary antibodies (Major Resources Table in the online-only Data Supplement). Images were acquired on a confocal microscope (Leica TSC SP-5 X) using 63×/1.4 NA HCX PlanApo or on a Leica DMIRBE inverted epifluorescence-Nomarski microscope with Leica TCS NT Laser Confocal optics.
Mouse Experimental Protocol
Male C57BL/6J (WT) mice or MPO-knockout (Mpo −/− ) mice aged 8 to 12 weeks were used (Major Resources Table in the onlineonly Data Supplement). As analgesic, buprenorphine (0.075 mg/ kg in sterile saline) was administered subcutaneously 30 minutes before commencing any surgical procedure. Mice were anesthetized with Isoflurane (5% for induction, 2% to 3% for maintenance). The carotid artery/jugular vein was cannulated for administering substances. The cremaster muscle was prepared, excised, and mounted on a stage for intravital microscopy as described. 19, 20 Mice were euthanized by terminal blood withdrawal from the vena cava. All animal experiments were approved by the local ethics committee (Landesamtes für Natur, Umwelt und Verbraucherschutz [LANUV]) and were in accordance with the Guide for the care and Use of Laboratory Animals.
Charge Assessment of the EG Using Alcian Blue 8GX
WT mice were treated intra-arterially with 150 μL of purified isolated human MPO (0.1 μg/µL), mutant catalytically inactive MPO (Q91T, 0.1 μg/μL), polylysine (0.1 μg/μL, Sigma number P4707), or HSA (human serum albumin, 0.1 μg/μL) for 15 minutes. Animals were euthanized and perfused with HBSS via the carotid artery at 2 mL/ min using a syringe pump to rinse all blood out. Thereafter, mice were stained with 0.1% Alcian Blue 8GX (EMS number 10350), rinsed, and fixed with 4% PFA via perfusion. The cremaster muscle was excised and placed flat on a micro slide for a short fixation with 4% PFA. The samples were dried and mounted using an aqueous mounting medium with weighted coverslips. The slides were dried overnight and viewed under bright field with a BZ-9000 microscope (Keyence). Acquired images of cremaster muscle vessels were analyzed with the BZ2 analyzer software (Keyence 
In Vivo Glycocalyx Shedding After Neutrophil Depletion
WT mice were injected 100 µL intraperitoneally with InVivoPlus antimouse Ly6G (2.5 μg/µL, Bio X cell number BP0075; Major Resources Table in the online-only Data Supplement) or saline. 21 Twenty-four hours later the mice underwent intra-arterial administration of 150 µL of human MPO, Q91T, polylysine, or HSA (all 0.1 μg/µL). The mice were treated for 15 minutes, after which blood from the vena cava was collected. The plasma was further used for quantification of Sdc1 using mouse Sdc1 ELISA (Cloud-Clone Corp number SEB966Mu).
Neutrophil Isolation and Activation
Peripheral blood was drawn from healthy human volunteers and heparinized, after which isolation was performed. 13 In brief, after sedimentation in dextran solution (45 mg/mL), the supernatant was placed over Histopaque 1077 (Sigma) for density gradient centrifugation. Remaining red blood cells were eliminated by hypotonic lysis and the pellet was resuspended in HBSS containing 0.25% BSA. Cells were counted and 0.5 million cells per well were seeded in a 24 well plate. The cells were allowed to adhere and were activated with PMA (phorbol myristate acetate; 100 nmol/L, Sigma) and fMLP (formyl-methionyl-leucyl-phenylalanine; 1 μmol/L, Sigma) in combination with polylysine treatment for 20 minutes on a shaker. The supernatant was further used for quantification of Sdc1 using a human Sdc1 ELISA kit (Diaclone number 950.640.048).
Quantitative Assessment of EG Thickness via Intravital Microscopy
EG thickness was measured in WT and Mpo −/− mice using the cremaster muscle model with FITC-dextran (FITC-dx) exclusion technique 22 on an upright intravital microscope (Olympus BX61WI) with X-Cite XLED1 as a light source for fluorescence excitation. Experiments were recorded using a digital CMOS camera (ORCA-Flash 4.0 V2) for high-speed acquisition and offline analyses. In brief, mouse carotid catheter was prepared and 200 µL FITC-dx (20 mg/mL, Sigma number 46946). Using bright field transillumination, the small blood vessels (arterioles and venules) were observed, with the focal plane set at the midplane of the vessel with the vessel wall visible. Using dark field and fluorescent excitation (450-495 nm) FITC-dx was detected. Images of bright field and dark field were acquired and later analyzed using cellSens software (Olympus).
EG thickness was measured in WT mice after 15 minutes of systemic treatment via carotid artery with 150 µL of human MPO (0.1 μg/µL), Q91T (0.1 μg/µL), polylysine (0.1 μg/µL), HSA (0.1 μg/µL), or heparin (0.33 U/µL). A group of WT mice were also given a 15 minutes heparin (0.33 U/µL) treatment, in addition to 15 minutes of MPO (0.1 μg/µL) treatment, to study the changes in EG thickness after release of vessel-bound MPO. 23 To study the effect of endogenous MPO released from neutrophils, recombinant murine TNF (tumor necrosis factor)-α (500 ng per mouse, R&D number T7539) in saline (or saline alone as a control) was injected into the scrotum of male WT and Mpo −/− mice. Two hours postinjection, intravital microscopy was performed to assess EG thickness.
Statistical Analyses
Normal distribution of the data was tested using Kolmogorov-Smirnov test, and equal variance was tested using F test or Bartlett test (for multiple samples). For normally distributed data with equal variance, Student unpaired t test was performed for 2-sample comparison and for multiple comparisons 1-way ANOVA followed by Tukey post hoc test or 2-way ANOVA followed by Fisher LSD post hoc test was used. For data not normally distributed, Mann-Whitney U test for 2-sample comparison and Kruskal-Wallis ANOVA on ranks followed by Dunn post hoc test for multiple comparisons was used. A P value <0.05 was considered as statistically significant. All statistical analyses were performed with GraphPad Prism 6. Data are presented as mean±SEM.
Results
The binding of MPO to the EG was first analyzed by in vivo staining of the EG with the cationic dye Alcian Blue 8GX (Figure 1) .
In support of the idea that charge modification affects MPO-GAG interaction, the migration of MPO toward the cathode using imidazole-HEPES-native PAGE was reduced dose-dependently with both heparin and chondroitin sulfate. This also provides evidence for MPO's electrostatic association with heparin and chondroitin GAG residues ( Figure  I in the online-only Data Supplement). Binding of MPO to GAG residues was further studied using CHO cells and their GAG-mutant cell lines. Expression of EG on CHO cells was confirmed via gene expression analysis of Sdc1 that showed a peak in expression after 4 days ( Figure II in the online-only Data Supplement). The amount of cell-adherent MPO (as reflected by MPO activity in the cell lysates) was reduced up to 4-fold in pgsA-745 (lacking heparan sulfate and chondroitin sulfate) and 3-fold in pgsD-677 (lacking heparan sulfate) as compared with WT CHO cells (Figure 2A) . Interestingly, no significant differences were observed in MPO catalytic activity between the 2 mutant cell lines. MPO bound to CHO cells was also visualized using immunofluorescence staining that revealed reduced binding of MPO to pgsA-745 and pgsD-677 cells as compared with WT CHO cells ( Figure 2B ). Similarly, cell-bound MPO levels were reduced up to 3-fold in both pgsA-745 and pgsD-677 as compared with CHO as assessed by Western blotting. Between pgsA-745 and pgsD-677, there were no significant differences in MPO levels ( Figure 2C ). Binding of MPO to the endothelial cell glycocalyx was also tested in culture with human umbilical vein endothelial cells ( Figure III in the online-only Data Supplement). The specific interaction of MPO to heparan sulfate was reconfirmed via immunofluorescence staining of human umbilical vein endothelial cells showing colocalization of MPO and heparan sulfate ( Figure 2D ).
The effect of MPO on EG integrity was explored in vivo using intravital microscopy. EG integrity was quantified in terms of EG thickness, using the FITC-dextran exclusion technique 22 on the cremaster muscle model. The technique was established and verified using WT mice treated with glycocalyx-degrading enzymes, which significantly reduced EG thickness as compared with saline treatment ( Figure IV in the online-only Data Supplement). In addition, baseline EG thickness was compared between WT and Mpo −/− mice. No significant differences were noted (Figure V in the online-only Data Supplement). Furthermore, WT mice were treated systemically via the carotid artery with MPO, Q91T, polylysine, or HSA (control) for 15 minutes. EG thickness was reduced significantly from 1.38±0.05 µm (HSA treatment) to 0.70±0.04 µm after MPO treatment (P<0.001; Figure 3A ). Similar effects were also observed after treatment with Q91T (0.59±0.03 µm; P<0.001) and polylysine (0.67±0.05 µm; P<0.001).
The modulation of EG integrity was further analyzed after removal of vessel-bound MPO by heparin. 23 Heparin treatment significantly increased EG thickness of MPOtreated mice (MPO+heparin) to 1.24±0.08 µm (Figure 3A) , suggesting that the reduction in EG thickness results from physical collapse and is partially reversible. To confirm the release of MPO, MPO plasma levels were measured using ELISA, which clearly showed that after the addition of heparin to MPO-treated mice there was a significant increase in circulating MPO plasma levels from 260 ng/mL to 20 µg/mL ( Figure 3B) .
The effect of endogenous MPO on the EG after inflammatory stimuli was investigated using WT and Mpo −/− mice and Mpo −/− mice were injected intrascrotally with TNF (tumor necrosis factor)-α before intravital microscopy. EG thickness was reduced significantly after TNF-α treatment as compared with saline treatment in WT mice. This effect was absent in Mpo −/− mice. Saline treatment was used as a control group; n=5-7-6-5. Bars represent means±SEM. One-way ANOVA was performed with *P<0.05, **P<0.01, and ***P<0.001. KO indicates knockout. treated locally (intrascrotally) for 2 hours with TNF-α or saline. In WT mice, the thickness of EG was reduced significantly from 1.29±0.04 µm to 0.68±0.05 µm (P<0.001), whereas in Mpo −/− mice no significant difference was observed after TNF-α treatment (Figure 4) .
The MPO-mediated modification of the EG was further characterized at the molecular level using quantification of Sdc1 plasma levels, which reflects EG shedding. Mice were treated with HSA, MPO, Q91T, or polylysine. Plasma levels of Sdc1 increased significantly from 51.11±7.84 ng/mL (HSA) to 81.11±7.5 ng/mL (P<0.05), 89.4±8.9 ng/mL (P<0.001) and 85.5±8.7 ng/mL (P<0.01) after treatment of mice with MPO, Q91T, and polylysine, respectively. Given the importance of MPO in neutrophil recruitment and release of MMP (matrix metalloproteinases) containing granules on neutrophil activation, Sdc1 plasma levels were also assessed after in vivo neutrophil depletion in WT mice. Interestingly, the increase in Sdc1 plasma levels was significantly attenuated in neutrophil-depleted mice. In MPO-treated mice, the Sdc1 levels were reduced to 50.6±16.9 ng/mL (P<0.05), in Q91T treated mice to 22.4±4.6 ng/mL (P<0.001), and in polylysine-treated mice to 51.8±6.5 ng/mL (P<0.05). The data suggest that, in addition to charge-mediated EG collapse, MPO induces neutrophil-dependent Sdc1 shedding ( Figure 5A ; Figure 6 for schematic explanation). Further, in vitro experiments using isolated human neutrophils were conducted to elucidate the contribution of neutrophil-derived Sdc1. No detectable levels of Sdc1 were observed in the supernatant after activation of neutrophils, indicating that neutrophil-derived Sdc1 does not contribute to the shedding observed in vivo ( Figure 5B ).
Discussion
In this study, we show that MPO leads to a collapse of the EG via binding with heparan sulfate GAG, causing shedding of Sdc1 in a neutrophil-dependent manner. Neutrophil recruitment is one of the most fundamental processes of the innate immune system. For a long time, it was believed that the neutrophil recruitment cascade is driven by 3 key stepsrolling mediated by selectins, cytokine-dependent activation, and arrest facilitated via integrins. 24, 25 Now, it is evident that the process is much more complex and involves additional steps postarrest such as integrin activation [26] [27] [28] and leukocyte migration. 29, 30 In our previous study, we have shown that MPO plays an important role during the first phase of neutrophil recruitment: MPO reduces the repulsion between the negatively charged EG and neutrophil glycocalyx, acting as a mediator independent of its catalytic function and purely dependent on its cationic charge. 17 Interestingly, there is some evidence that removal of heparan sulfate GAG from perlecan reduces the binding of MPO. 31 However, it still remains uncharacterized how MPO binds to the EG and how it influences vascular integrity.
Binding of heparin/heparan sulfate to proteins is known to be facilitated by heparin/heparan sulfate binding sites, which are formed by 2 to 7 cationic surface amino acids, arginine, and lysine. 32, 33 The surface of MPO contains >70 of these amino acids allowing for multiple binding sites. The interaction via these heparin/heparan sulfate binding sites can thus be considered to be rather nonspecific and a wide variety of GAG motifs can interact with the numerous binding sites on the surface of MPO. It is this ionic interaction of MPO with the glycocalyx heparan sulfate GAG that leads to EG collapse, which might facilitate neutrophil binding to the endothelial cell ( Figure 6 ).
In unstimulated vessels, adherent neutrophils are rarely seen, as the adhesion molecules are well shielded by the EG layer. 34, 35 The longest known adhesion molecule pair, P-selectin-PSLG1, only measures 75 nm in height, which is -1) . A, Neutrophils were depleted in wild-type (WT) mice via anti-Ly6G antibody; saline was used in nondepleted mice. Mice were then treated intra-arterially with MPO and mutant inactive MPO (Q91T). HSA (human serum albumin) was used as a control. Sdc1 plasma levels were measured using ELISA. There was a significant increase in the Sdc1 levels after treatment with MPO, Q91T, and polylysine as compared with HSA treatment, which was attenuated after neutrophil depletion; n=7-6-7-6-7-6-10-5. B, In vitro experiments with freshly isolated human neutrophils were conducted to elucidate the contribution of neutrophil-derived Sdc1. Neutrophils were treated +/− polylysine and +/− PMA (phorbol myristate acetate) and fMLP (formyl-methionyl-leucyl-phenylalanine); n=6. Bars represent means±SEM. Two-way ANOVA (A) and 1-way ANOVA (B) was performed with *P<0.05, **P<0.01, and ***P<0.001. much smaller than the EG. 34 Furthermore, because of electrostatic repulsion from the EG, negatively charged molecules are known to penetrate the EG significantly slower. 4 The chargemediated collapse of the EG via MPO seems to be a unique mechanism regulating neutrophil recruitment and modulating innate immune defense. In addition to host defense, MPO-EG interaction might have beneficial and preventive effects in pathologies like sepsis. It is known that MPO plasma levels profoundly increase under septic conditions. 36 It interacts with acute phase anionic proteins like α-antitrypsin or ceruloplasmin, thereby balancing oxidative responses and regulating inflammation. 37, 38 One of the main threats for septic patients is the massive dilatation of peripheral vessels. The EG is a key player in regulating mechanotransduction. 39 Thus, the MPOmediated modulation of the EG could potentially be a mechanism to reduce flow-mediated vasodilation and help maintain peripheral vascular resistance.
One of the first attempts to visualize the EG was made using ruthenium red with classical transmission electron microscopy.
1 Decades later, transmission electron microscopy protocols were modified using different reagents for fixation and staining using Alcian Blue or lanthanum nitrate, allowing better visualization of the EG. 40, 41 Apart from direct visualization, the EG can also be studied using indirect methods. Microparticle image velocimetry is one such example, where velocity profiles of fluorescent microparticles near the vessel wall provide information on glycocalyx integrity. 42 Another example is the FITC-dextran exclusion technique, where the glycocalyx is predicted as an exclusion zone along the sides of the vessel using FITC-labeled dextran of 70 kDa. 22 Using a modified version of this latter technique, we were able to estimate EG thickness of ≈1.5 µm ( Figure 3A) . We performed intravital microscopy with high molecular weight FITC-dextran (150 kDa), because of the reported impurities in lower molecular weight dextran. In addition, X-Cite XLED and CMOS ORCA-Flash 4.0 V2 camera was used to reduce illumination-induced effects and to increase resolution. The EG structure collapsed, as observed by reduction in thickness after treatment with cationic molecules such as MPO, Q91T, and polylysine. These effects of MPO were partially restored after removal of bound MPO by heparin ( Figure 3A) . The modulation of the EG by MPO seems solely dependent on its cationic surface charge and is independent of its enzymatic properties (Figure 1 ). This was in accordance with other studies, which have revealed that changes in the glycocalyx charge induce alteration of glycocalyx structure and function. 18 Some limitations of our study need to be taken into account. First, about the restoration of the EG after heparin administration in MPO-treated mice ( Figure 3A) . One cannot exclude the possibility of incorporation of heparin molecules into the collapsed EG and thus a heparin-dependent restoration. However, the strong spike in MPO plasma levels after heparin treatment (in MPO-treated mice) provides evidence of a significant release of immobilized MPO and thereby points toward an MPO-mediated effect ( Figure 3B) . Further, the collapse of the glycocalyx based on MPO's cationic charge could not be visualized using transmission electron microscopy, as most stains such as Alcian Blue, ruthenium red, or cupromeronic blue also possess a cationic charge and can interact with the glycocalyx in the same way as MPO.
Neutrophil primary granules are rich in other cationic proteins such as proteinase 3, cathepsin G, elastase, etc. 43 We speculate that the charge-mediated effects are not specific for MPO but are exhibited by other neutrophil cationic proteins. However, given the abundance of MPO in neutrophils 44 and its high concentration in the plasma, 11 MPO emerges as a key mediator of EG collapse. Interestingly, neutrophils are known to be activated and to degranulate on high-fat diet. There are various proposed mechanisms such as an increase Figure 6 . Proposed mechanism of MPO (myeloperoxidase)-mediated modulation of endothelial glycocalyx (EG) integrity. The upright hair-like structure of the EG is destabilized by MPO's cationic charge leading to a physical and reversible collapse of the EG. Steric hindrance and ionic repulsion of the EG is reduced, allowing easy recruitment and activation of neutrophils. On activation, proteinase-containing granules are released, leading to neutrophil-dependent shedding of Sdc1 (syndecan-1) proteoglycan. This mechanism is a unique example of MPO's impact on vascular homeostasis based on its cationic charge that crucially influences endothelial cell function. GAG indicates glycosaminoglycan.
in neutrophil microvesicles causing activation of endothelial cells and neutrophils 45 or C5a-mediated activation of neutrophils induced by high-fat diet. 46 Given the crucial damage to the EG in atherosclerosis or metabolic disorders, [47] [48] [49] [50] deciphering underlying mechanisms for neutrophil activation and degranulation in such diseases could provide new insights into pathways mediating vascular inflammation.
Given that MPO physically attracts neutrophils and propagates their activation, we suggest that modulation of the EG structure is a prerequisite for such phenomena to occur. 16, 17 Sdc1 shedding is induced by MMP and is an established biomarker for assessing EG integrity. 51, 52 Neutrophil granules contain MMP and are released on activation. 53, 54 Therefore, EG modulation was evaluated in terms of Sdc1 shedding and its possible link with neutrophil recruitment and activation. We observed that the charge-mediated modulation of the EG by MPO, Q91T, or polylysine led to an increase in Sdc1 plasma levels that was indeed neutrophil-dependent and was attenuated after their depletion ( Figure 5A ). Thus, a collapse of the EG structure possibly leads to neutrophil recruitment and activation, with the release of MMP-containing granules causing Sdc1 shedding ( Figure 6 ).
MPO has evolved from being an enzyme involved in innate host defense to a critical mediator of inflammatory vascular diseases, both dependent and independent of its catalytic function. Here, we have shown that MPO independent of its catalytic properties binds to the EG via heparan sulfate side chains, causing a collapse of the EG. It is this collapse that leads to neutrophil-dependent shedding of Sdc1 and that is potentially also an initiator of neutrophil recruitment ( Figure 6 ). These studies support MPO's distinctive role in crucially altering endothelial function and its potential influence on vascular properties.
